Phase I Trial of Sequential Administration of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Phase I Trial of Sequential Administration of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small-Cell Lung Cancer

Published:2006-06 Issue:6 Volume:13 Page:1185-1191
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Nemunaitis John,Meyers Thomas,Senzer Neil,Cunningham Casey,West Howard,Vallieres Eric,Anthony Stephen,Vukelja Svetislava,Berman Barry,Tully Heather,Pappen Beena,Sarmiento Stephen,Arzaga Rosemarie,Duniho Steven,Engardt Susan,Meagher Madeleine,Cheever Martin A.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference17 articles.

1. Revisions in the International System for Staging Lung Cancer;Mountain;Chest,1997

2. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer;Winton;N. Engl. J. Med.,2005

3. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N. Engl. J. Med.,2004

4. A randomized trial of adjuvant chemotherapy with uracil–tegafur for adenocarcinoma of the lung;Kato;N. Engl. J. Med.,2004

5. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): report of Cancer and Leukemia Group B (CALGB) Protocol 9633;Strauss;J. Clin. Oncol.,2004

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The progress of tumor vaccines clinical trials in non-small cell lung cancer;Clinical and Translational Oncology;2024-08-23

2. Genetically Engineered Microorganisms and Their Impact on Human Health;International Journal of Clinical Practice;2024-03-09

3. Non-immune cell components in tumor microenvironment influencing lung cancer Immunotherapy;Biomedicine & Pharmacotherapy;2023-10

4. Novel Therapeutic Approaches Targeting Post-Translational Modifications in Lung Cancer;Pharmaceutics;2023-01-06

5. Multifaceted Applications of Genetically Modified Micro-organisms: A Biotechnological Revolution;Current Pharmaceutical Design;2022-06